SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 217 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.66 and the average weighting 0.2%.

Quarter-by-quarter ownership
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$36,000
-73.1%
2,325
-61.1%
0.02%
-60.5%
Q1 2018$134,000
-22.1%
5,977
+4.4%
0.04%
-24.0%
Q4 2017$172,000
+3.0%
5,727
+29.4%
0.05%
-10.7%
Q3 2017$167,000
+33.6%
4,427
-1.2%
0.06%
+24.4%
Q2 2017$125,000
+81.2%
4,479
+60.5%
0.04%
+28.6%
Q3 2014$69,000
+72.5%
2,790
+59.4%
0.04%
+84.2%
Q2 2014$40,000
+471.4%
1,750
+483.3%
0.02%
+850.0%
Q1 2014$7,0000.0%3000.0%0.00%0.0%
Q4 2013$7,0003000.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Baker Brothers Advisors 27,228,338$611,821,0005.19%
First Washington CORP 176,950$3,976,0002.06%
SECTORAL ASSET MANAGEMENT INC 783,424$17,604,0001.93%
HARVEY CAPITAL MANAGEMENT INC 219,042$4,921,0001.84%
Ghost Tree Capital, LLC 400,000$8,988,0001.82%
Opus Point Partners Management, LLC 36,733$825,0001.62%
Palo Alto Investors LP 1,650,780$37,093,0001.59%
EMORY UNIVERSITY 84,714$1,904,0001.36%
GARRISON BRADFORD & ASSOCIATES INC 69,000$1,550,0001.32%
HealthCor Management, L.P. 1,378,000$30,964,0001.05%
View complete list of ACADIA PHARMACEUTICALS INC shareholders